
    
      The trial is a randomized controlled multi-center non-inferiority trial. The primary outcome
      measure is success rate at 1-year follow-up. The second outcomes are subjective improvement
      of quality of life, complications and costs. Analysis will be performed according to the
      intention to treat principle. Based on comparable success rate of 90% and 10% as the
      margin(beta 0.2 and one sided alpha 0.025), about 312 patients in total from 11 centers will
      be recruited per group including 10% drop-out. The aims of the research are to demonstrate
      whether self-tailored mesh is non-inferior to the mesh-kit. The finding of this research
      might influence the treatment selection for POP in China.
    
  